It was interesting to observe that the asthma patients who carried lowly expressed MALAT1 and highly expressed miR-155 were more prone to reveal higher FEV1 (>1.95 l), FEV1/FVC (>71.55%), predicted FEV1% (>78.91%) and FeNO (≤51.27 μg/l) than highly expressed MALAT1 group and lowly expressed miR-155 group (P<0.05). The gene discussed is MALAT1; the disease is asthma.